Apixaban Prices Surge Amid Increased Demand for Anticoagulant Medications

𝐊𝐨𝐫𝐞𝐚 𝐀𝐩𝐢𝐱𝐚𝐛𝐚𝐧 𝐏𝐥𝐚𝐭𝐞 𝐏𝐫𝐢𝐜𝐞𝐬 𝐌𝐨𝐯𝐞𝐦𝐞𝐧𝐭 𝐐𝟏

𝐀𝐩𝐢𝐱𝐚𝐛𝐚𝐧 𝐏𝐥𝐚𝐭𝐞 𝐏𝐫𝐢𝐜𝐞𝐬 𝐢𝐧 𝐊𝐨𝐫𝐞𝐚:

As for apixaban, by March 2024, the prices available in South Korea was 43,000 USD/Ton The price during the first quarter was much the same as had been observed in the last quarter for all practical purposes, with little variation from changes in demand and production dynamics. The usage of widely prescribed blood-thinning medication apixaban maintained steady demand from health care and pharmaceutical sectors as a result of the rising incidence of cardiovascular diseases.

This demand pattern continued with the growing number of patients requiring blood-thinning medicine and the many treatment modalities associated with this drug. Despite the demands of this emerging market, other phenomena such as increased costs for the raw materials needed in the manufacture, as well as problems associated with the complexity involved in running processes of high quality, forced the price upwards. This is the much higher price levels seen during this period.

Supply condition showed that local manufacturers in South Korea remained consistent, leaving production levels stable to thus serve the domestic and international requirements. There is, however, a limited price increase caused by competition with other anticoagulant therapies and generic drugs available, thus creating a fairly balanced market despite continuous demand.

The economic dynamics of trade also played its parts with activities. The development of strong export channels for apixaban further contributed to stability in prices at the local level for the benefits of the South Korean pharmaceutical industry. Still, there is a pressure on improving operational efficiency because of expanding logistical constraints and changing regulatory requirements in export destinations.

Thus, on the whole, the apixaban market during quarter one of 2024 in South Korea managed to portray a steady price across the years, thanks to the pull of the strong demand from the health care sector and balanced supply chain efficiencies. As evident in the market stability, it was usually

𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗙𝗼𝗿 𝗮 𝗦𝗮𝗺𝗽𝗹𝗲 𝗖𝗼𝗽𝘆 𝗼𝗳 𝘁𝗵𝗲 𝗥𝗲𝗽𝗼𝗿𝘁: https://www.imarcgroup.com/apixaban-pricing-report/requestsample

𝐇𝐨𝐰 𝐈𝐌𝐀𝐑𝐂 𝐏𝐫𝐢𝐜𝐢𝐧𝐠 𝐃𝐚𝐭𝐚𝐛𝐚𝐬𝐞 𝐂𝐚𝐧 𝐇𝐞𝐥𝐩

The latest IMARC Group study, "𝐀𝐩𝐢𝐱𝐚𝐛𝐚𝐧 𝐏𝐥𝐚𝐭𝐞 𝐏𝐫𝐢𝐜𝐞𝐬, 𝐓𝐫𝐞𝐧𝐝, 𝐂𝐡𝐚𝐫𝐭, 𝐃𝐞𝐦𝐚𝐧𝐝, 𝐌𝐚𝐫𝐤𝐞𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬, 𝐍𝐞𝐰𝐬, 𝐇𝐢𝐬𝐭𝐨𝐫𝐢𝐜𝐚𝐥 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐃𝐚𝐭𝐚 𝟐𝟎𝟐𝟒 𝐄𝐝𝐢𝐭𝐢𝐨𝐧," presents a detailed analysis of Apixaban Plate price trend, offering key insights into global Apixaban Plate market dynamics. This report includes comprehensive price charts, which trace historical data and highlights major shifts in the market.

The analysis delves into the factors driving these trends, including raw material costs, production fluctuations, and geopolitical influences. Moreover, the report examines Apixaban Plate demand, illustrating how consumer behavior and industrial needs affect overall market dynamics. By exploring the intricate relationship between supply and demand, the prices report uncovers critical factors influencing current and future prices.

𝗦𝗽𝗲𝗮𝗸 𝘁𝗼 𝗮𝗻 𝗔𝗻𝗮𝗹𝘆𝘀𝘁: https://www.imarcgroup.com/request?type=report&id=22910&flag=C

𝗖𝗼𝗻𝘁𝗮𝗰𝘁 𝘂𝘀:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
𝗘𝗺𝗮𝗶𝗹: sales@imarcgroup.com
𝗧𝗲𝗹 𝗡𝗼: (D) +91 120 433 0800
𝗨𝗻𝗶𝘁𝗲𝗱 𝗦𝘁𝗮𝘁𝗲𝘀: +1-631-791-1145

𝗔𝗯𝗼𝘂𝘁 𝗨𝘀:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, and benchmarking analyses, pricing and cost research, and procurement research.

This release was published on openPR.